SS Innovations Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System

Company’s flagship SSi Mantra surgical device has now been used in more than 1000 procedures

FORT LAUDERDALE, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful performance of the first pyeloplasty procedure performed on an infant utilizing its flagship SSi Mantra Surgical Robotic System. The successful surgery was performed by Dr. Chandra Mohan Vaddi at the Preeti Urology & Kidney Hospital in Hyderabad, India.

The pyeloplasty procedure, which involves the surgical reconstruction of the renal pelvis to remove a blockage that prevents urine from properly draining into the bladder, was successfully completed on a 12 month old baby weighing 8.5 kilograms (approximately 17.6 pounds).

“Words can hardly express the overwhelming joy and pride we feel as we witness the SSi Mantra Surgical Robotic System changing the trajectory of children's lives,” said Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations. “This milestone is a testament to the precision and adaptability of the SSi Mantra in meeting the nuanced requirements of pediatric care. It underscores our commitment to extending state-of-the-art surgical options to all patient demographics, including the most vulnerable. From the very beginning, our vision for our surgical robotic system was to revolutionize healthcare for everyone, including children, ensuring that even the most delicate surgeries are performed with unmatched precision and care.”

The SSi Mantra Surgical Robotic System is the first surgical system to be made in India, and one of the only systems in the world to be cost-effective with broad-spectrum surgical applications. It has been granted regulatory approval in India, Guatemala and Indonesia, and is clinically validated in more than 60 different types of surgical procedures, including pyeloplasty. More than 1000 surgical procedures have been performed using the system to date including cardiothoracic, head and neck, gynecology, urology, and general surgeries in India. SS Innovations has commenced the regulatory approval process in the United States and European Union, and anticipates receiving such approvals in the latter half of 2024 or-2025.